Bio-Rad Laboratories Inc (BIO)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-637,300	-159,300	-428,400	-191,214	-3,627,564	-6,027,464	-1,935,064	-93,150	4,254,200	6,665,600	4,050,800	4,100,400	3,806,300	3,520,600	1,947,000	1,579,400	1,758,700	376,700	904,800	574,000
Total assets	US$ in thousands	12,299,100	11,895,900	11,978,200	13,667,400	13,501,700	12,058,500	12,682,100	14,373,700	17,799,400	19,953,400	15,117,600	13,933,200	12,972,600	12,020,900	10,097,300	8,684,360	8,008,860	7,177,100	7,646,900	6,862,900
ROA		-5.18%	-1.34%	-3.58%	-1.40%	-26.87%	-49.99%	-15.26%	-0.65%	23.90%	33.41%	26.80%	29.43%	29.34%	29.29%	19.28%	18.19%	21.96%	5.25%	11.83%	8.36%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $-637,300K ÷ $12,299,100K
= -5.18%

Bio-Rad Laboratories Inc.'s return on assets (ROA) has shown varying performance over the past eight quarters. The ROA values range from -50.05% to -1.29% during this period. ROA measures the company's ability to generate profits from its assets, with higher values indicating better efficiency.

In the most recent quarter, Q4 2023, Bio-Rad Laboratories Inc. reported an ROA of -5.18%, reflecting a decrease in profitability compared to the previous quarter. This negative ROA suggests that the company's net income generated from its assets was insufficient to cover its total assets, leading to a lower return.

Looking back at Q4 2022, Bio-Rad Laboratories Inc. experienced a significantly lower ROA of -26.87%, followed by a sharp decline to -50.05% in Q3 2022. These negative ROA values indicate that the company faced challenges in effectively utilizing its assets to generate profits during that time.

Overall, the trend in Bio-Rad Laboratories Inc.'s ROA suggests a fluctuating performance in converting its assets into earnings. Investors and analysts may want to further investigate the company's operational efficiency and asset management strategies to improve its return on assets in the future.